WO2004105759A3 - Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantantonisten enthaltend zur behandlung von atemwegserkrankungen - Google Patents

Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantantonisten enthaltend zur behandlung von atemwegserkrankungen Download PDF

Info

Publication number
WO2004105759A3
WO2004105759A3 PCT/EP2004/005219 EP2004005219W WO2004105759A3 WO 2004105759 A3 WO2004105759 A3 WO 2004105759A3 EP 2004005219 W EP2004005219 W EP 2004005219W WO 2004105759 A3 WO2004105759 A3 WO 2004105759A3
Authority
WO
WIPO (PCT)
Prior art keywords
respiratory tract
treatment
anticholinergic agent
tract diseases
novel long
Prior art date
Application number
PCT/EP2004/005219
Other languages
English (en)
French (fr)
Other versions
WO2004105759A2 (de
Inventor
Ingo Konetzki
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Pharma
Ingo Konetzki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Pharma, Ingo Konetzki filed Critical Boehringer Ingelheim Int
Priority to CA002527178A priority Critical patent/CA2527178A1/en
Priority to JP2006529830A priority patent/JP2007500194A/ja
Priority to EP04739209A priority patent/EP1631287A2/de
Publication of WO2004105759A2 publication Critical patent/WO2004105759A2/de
Publication of WO2004105759A3 publication Critical patent/WO2004105759A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die vorliegende Erfindung betrifft neuartige Arzneimittelkompositionen auf der Basis eines neuen Anticholinergikums und eines neuen langwirksamen Beta2-Agonisten, Verfahren zu deren Herstellung sowie deren Verwendung bei der Therapie von Atemwegserkrankungen.
PCT/EP2004/005219 2003-05-27 2004-05-14 Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantantonisten enthaltend zur behandlung von atemwegserkrankungen WO2004105759A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002527178A CA2527178A1 (en) 2003-05-27 2004-05-14 New long-acting drug combinations for the treatment of respiratory complaints
JP2006529830A JP2007500194A (ja) 2003-05-27 2004-05-14 呼吸器疾患治療用の新規な長時間作用型医薬の組合せ
EP04739209A EP1631287A2 (de) 2003-05-27 2004-05-14 Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantagonisten enthaltend zur behandlung von atemwegserkrankungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323966A DE10323966A1 (de) 2003-05-27 2003-05-27 Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE10323966.9 2003-05-27

Publications (2)

Publication Number Publication Date
WO2004105759A2 WO2004105759A2 (de) 2004-12-09
WO2004105759A3 true WO2004105759A3 (de) 2005-01-20

Family

ID=33441345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/005219 WO2004105759A2 (de) 2003-05-27 2004-05-14 Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantantonisten enthaltend zur behandlung von atemwegserkrankungen

Country Status (5)

Country Link
EP (1) EP1631287A2 (de)
JP (1) JP2007500194A (de)
CA (1) CA2527178A1 (de)
DE (1) DE10323966A1 (de)
WO (1) WO2004105759A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9463161B2 (en) 2009-05-29 2016-10-11 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080036632A (ko) 2005-08-08 2008-04-28 아젠터 디스커버리 리미티드 바이시클로[2.2.1]헵트-7-일아민 유도체 및 이들의 용도
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
CA2650813A1 (en) * 2006-05-24 2007-11-29 Boehringer Ingelheim International Gmbh New long-acting drug combinations for the treatment of respiratory diseases
WO2007134964A1 (en) * 2006-05-24 2007-11-29 Boehringer Ingelheim International Gmbh Novel medicament combinations for the treatment of respiratory diseases
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032899A1 (de) * 2000-10-14 2002-04-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
WO2002066422A1 (en) * 2001-02-14 2002-08-29 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032899A1 (de) * 2000-10-14 2002-04-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
WO2002066422A1 (en) * 2001-02-14 2002-08-29 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9463161B2 (en) 2009-05-29 2016-10-11 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems

Also Published As

Publication number Publication date
DE10323966A1 (de) 2004-12-16
JP2007500194A (ja) 2007-01-11
WO2004105759A2 (de) 2004-12-09
CA2527178A1 (en) 2004-12-09
EP1631287A2 (de) 2006-03-08

Similar Documents

Publication Publication Date Title
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
HK1085127A1 (en) A use of antipsychotics in the manufacture of medicine delivered by ; inhalation for treatment of headache
PT1408967E (pt) Composições de medicamentos com base em tiotrópio, ciclesonida e um betamimético para o tratamento de doenças respiratórias inflamatórias e/ou obstrutivas
IL164373A (en) Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer
WO2006031398A3 (en) Compositions containing fast-leaching plasticizers for improved performance of medical devices
IL168279A (en) Use of liposomal and aminoglycoside composition to prepare a drug for the treatment or improvement of infection
IL153920A (en) Somatostatin analogues, processes for their production, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
BG108443A (en) Substituted oxazoliidinones for combinational therapy
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
WO2003084539A3 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
IL226313A0 (en) A method for producing gamma-carboxylated human prothrombin, isolated prothrombin produced by such a method, a pharmaceutical preparation including it and its use as drugs and for the production of drugs for the treatment of blood coagulation
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2004105759A3 (de) Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantantonisten enthaltend zur behandlung von atemwegserkrankungen
IL166596A0 (en) Salt of morphine-6-glucoronide
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
WO2005094798A3 (en) Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
WO2002074034A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und endothelinantagonisten
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
WO2005011615A3 (en) Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004739209

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2527178

Country of ref document: CA

Ref document number: 2006529830

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2004739209

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004739209

Country of ref document: EP